Bioavailability Study of Candesartan Cilexetil 16mg Tablet Under Fasting Conditions
NCT02006602
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Candesartan cilexetil (GW615775, Test formulation)
DRUG:
Candesartan cilexetil (Reference treatment)
Sponsor
GlaxoSmithKline